CN1733038A - Novel drug administering route of saussurea involucrate injection and its preparation process - Google Patents

Novel drug administering route of saussurea involucrate injection and its preparation process Download PDF

Info

Publication number
CN1733038A
CN1733038A CN 200510087732 CN200510087732A CN1733038A CN 1733038 A CN1733038 A CN 1733038A CN 200510087732 CN200510087732 CN 200510087732 CN 200510087732 A CN200510087732 A CN 200510087732A CN 1733038 A CN1733038 A CN 1733038A
Authority
CN
China
Prior art keywords
injection
filter
filtrate
sterilization
herba saussureae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510087732
Other languages
Chinese (zh)
Inventor
刘露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Fukangren Bio Pharm Tech Co Ltd
Original Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Fukangren Bio Pharm Tech Co Ltd filed Critical Beijing Fukangren Bio Pharm Tech Co Ltd
Priority to CN 200510087732 priority Critical patent/CN1733038A/en
Publication of CN1733038A publication Critical patent/CN1733038A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to the novel route for administration of Chinese medicinal injection for treating acute, chronic rheumatic arthritis, rheumatoid arthritis and joint ache caused by ostarthritis, the process for its preparation, and new indications. The injection is prepared from Tianshan snow saussurea as the raw material, and can be made into concentrated solution, freeze-dried powder injection, germ-free powder, 5% glucose injection, and 0.9% sodium chloride injection.

Description

Route of administration that the snow lotus injection agent is new and preparation technology thereof
Technical field:
The present invention relates to the agent of Chinese medicine preparation snow lotus injection new route of administration and preparation technology thereof.
Technical background:
Arthritis is one group of diseases associated with inflammation that involves the joint of general reference, the position that is the pathological changes infringement is the joint of human body, that the joint has is red, swollen, hot, bitterly, handicapped inflammation performance, or each tissue that constitutes the joint on the pathology have rotten, ooze out, hypertrophy sexually revises and is arthritis.In China, 100,000,000 above arthritics are arranged.Doctors confirm that the arthritic is just increasing with surprising numeral, and arthritic ill situation worsens rapidly.What problem was more serious is, those people that are about to become the arthritic do not know how to prevent, and many arthritics also know nothing Therapeutic Method, some people even do not know it oneself is the arthritic.
At present, the Chinese medicine and western medicine of treatment of arthritis is a lot, but western medicine arthritis effect is undesirable, and Chinese medicine has special advantages aspect treatment of arthritis, utilize anti-inflammatory analgesic, detumescence method treatment of arthritis that certain effect is arranged.
Herba Saussureae Involueratae belongs to herbaceos perennial for the Compositae Radix Aristolochiae, and the Herba Saussureae Involueratae injection that is extracted by the Herba Saussureae Involueratae herb has anti-inflammatory analgesic, blood circulation promoting and blood stasis dispelling function, clinical rheumatic arthritis, rheumatoid arthritis, the osteoarthritis etc. of being used for the treatment of.
The effective ingredient of Herba Saussureae Involueratae injection is a total flavones.Modern pharmacology confirms that antiinflammatory action is the general character of flavone compound, and its mechanism of action is to suppress phospholipase A 2Activity, thereby reduced the generation of prostaglandin and leukotriene.
The total flavones that kinds of experiments demonstrates in the Herba Saussureae Involueratae injection can significantly increase the synthetic of chondrocyte proteoglycan, protein and DNA, thereby brings into play its antiinflammatory, detumescence, analgesia, curing rheumatism, dredge the meridian passage, human body immunity improving power, effects such as blood circulation promoting and blood stasis dispelling.
But, Herba Saussureae Involueratae injection adopts the intramuscular injection method aspect clinical practice, absorb by tissue, speed is slower, and dosage is less, effect to diseased region is less, and both increased patient's misery, also can cause the injection site scleroma, even swell and ache, secondary infection, often having an injection also causes " hip contracture " easily.This administrated method significantly limits its clinical practice.Therefore, at this problem, we have developed the intravenously administrable approach, have overcome to absorb shortcoming slow, that onset time is long.Both increased clinical effective dose, and can comparatively fast absorb again, blood drug level is higher, has improved bioavailability, and more convenient for clinical practice, more preferably the patient serves.
Summary of the invention:
The invention provides the agent of folk prescription snow lotus injection, be raw material and add the suitable medicinal ejection preparation that suitable adjuvant is prepared from by Herba Saussureae Involueratae.
Preparation type involved in the present invention, comprise small-volume injection (injection, concentrated solution for injection), bulk capacity injection (5% glucose injection, 0.9% sodium chloride injection) and specific type injection dosage forms such as (lyophilized powder, sterilized powders), wherein:
(1) preparation process of injection is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, it is an amount of that filtrate adds F-68, stirs, and with 40% sodium hydroxide solution regulated value to 6.0~8.0, filters with microporous filter membrane (0.2 μ m), and filtrate adds the nearly full dose of injection water, embedding, and sterilization, promptly.
(2) preparation process of freeze-dried powder is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds an amount of and mannitol of F-68 and stirs, with 40% sodium hydroxide solution regulated value to 6.0~8.0, filter with microporous filter membrane (0.2 μ m), filtrate adds injection water nearly full dose, the filtrate fill in the cillin bottle of 15ml, every bottled 2~7ml.And be placed in the freeze drying box pre-freeze evacuation after 3~5 hours.After the lyophilization 24 hours, tamponade, roll lid, make dried frozen aquatic products, promptly;
(3) preparation process of sterilized powder is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Getting this solution filters, filtrate adds F-68 and mannitol is an amount of, stir, with 40% sodium hydroxide solution regulated value to 6.0~8.0, after an amount of dissolving of adding mannitol, filter with microporous filter membrane (0.2 μ m), filtrate is sprayed with the spray drying tower under the aseptic condition, makes sterilized powder, packing, labeling, promptly.
(4) preparation of concentrated solution for injection: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and mannitol is an amount of, stirs, with 40% sodium hydroxide solution regulated value to 6.0~8.0, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.
The preparation of (5) 5% glucose injections: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 10g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and glucose is an amount of, stirs, with 40% sodium hydroxide solution regulated value to 6.0~8.0, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.
The preparation of (6) 0.9% sodium chloride injections: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 10g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and sodium chloride is an amount of, stirs, and with 40% sodium hydroxide solution regulated value to 6.0~8.0, filters with microporous filter membrane (0.2 μ m), and filtrate is evaporated under aseptic condition in right amount, embedding, and sterilization, promptly.
During more than prescription was formed, the weight of raw material of Chinese medicine medicine was calculated with crude drug, and per 1 part can be 1 gram, also can be kilogram or ton, if be unit with gram, this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as 1000 of injection, freeze-dried powder is 1000 bottles, each consumption is 1~3 (or bottle).
Folk prescription snow lotus injection of the present invention agent, the liquid unit dosage forms of preparation contains active substance of the present invention and sterile carrier.According to carrier and concentration, this chemical compound can be suspended or dissolving.The preparation of solution is normally by being dissolved in active substance in a kind of carrier filter-sterilized before it is packed into a kind of suitable bottle or ampoule, sealing then.For example a kind of local anesthetic of adjuvant, antiseptic and buffer agent also can be dissolved in this carrier.In order to improve its stability, can be after the bottle of packing into that this compositions is freezing, and under vacuum, water is removed.
Folk prescription snow lotus injection preparation of the present invention as injection, can be drawn 1~3 with disposable syringe in use, adopts intramuscular injection, and after also pharmaceutical liquid can being diluted with 0.9% normal saline, 10~40ml, intravenous injection was slowly injected in 5~8 minutes; Also can be diluted in 0.9% sodium chloride injection or 5% glucose injection, 250~500ml, vein splashes into.For lyophilized injectable powder, can adopt the said method administration with after the sterilized water for injection dissolving.
Following data declaration beneficial effect of the present invention by experiment:
For the whether equivalence of the curative effect that proves new route of administration and original route of administration, or be any more effective, we have compared the curative effect difference of intravenously administrable and two kinds of administering modes of intramuscular administration with regard to the clinical efficacy of Herba Saussureae Involueratae injection, done preclinical zoopery, concrete grammar and result are as follows:
One, to the influence of antiinflammatory and analgesic activity
1, animal and material
NIH mice and SD rat; Herba Saussureae Involueratae injection (Western Regions, Xinjiang pharmaceutical factory); Carrageenin; 1640 culture medium; Concanavalin A, Con A; Lipoprotein etc.
2, method and result
2.1 bringing out the influence of rat foot claw swelling, on Carrageenan chooses 40 of healthy rats, body weight 186 ± 35g, be for 5 monthly ages, the male and female dual-purpose, be divided into two groups of intravenously administrable experimental group and intramuscular administration matched groups according to the body weight equilibrium, each organizes the volume (mmHg post) of all measuring right back pawl before the rat administration with sufficient pawl analyzer.Continuous use is 3 days then, causes the swelling degree that rat foot claw is surveyed in scorching back with carrageenin after the last administration.The result shows two groups of swelling degree that all can obviously suppress rat foot claw of Herba Saussureae Involueratae injection, but intravenously administrable group curative effect obviously is better than the intramuscular administration group, and the experimental group suppression ratio is 25~59%, and matched group is 18~42%; The acting duration of experimental group is more than 6 hours, and matched group is 4 hours, and intensity obviously is better than matched group.
2.2 analgesic activity
50 of healthy female mices, body weight 25 ± 1.6g eases pain incubation period within 30s.Be divided into negative control group (NS) according to the body weight equilibrium, intramuscular injection Herba Saussureae Involueratae injection positive controls (10ml/kg), intravenous injection Herba Saussureae Involueratae injection experimental group (10ml/kg).Once a day, logotype is 7 days.1h after the last administration measures and record mice pain incubation period the result with hot plate method, two groups of Herba Saussureae Involueratae injections all can make prolongation of latency with respect to negative control group, but with the intravenously administrable group serves as strong, and effect continued more than 5 hours, and the two relatively has notable difference (P<0.05).
2.3 analgesia and repair to central nervous system injury
Get 30 of healthy adult dogs, body weight 11~15kg is divided into two groups at random, and promptly experimental group is 15,15 of matched groups.Two groups all add local anaesthesia in ketamine 10mg/kg intramuscular injection and finish epidural puncture and put pipe, disappear to local anaesthesia, animal is clear-headed fully, push 1.5% lignocaine 5ml through conduit, when all hemorrhage two backs acroparalysis is unable, confirm that conduit is in chamber, the dura mater outside, with Herba Saussureae Involueratae injection intravenous injection 5ml/ time, once a day, continuous 7 days, take out behind the conduit and observed 2 months.Found that the continuous observation of experimental group and matched group is after 2 months, 15 dogs of experimental group are with respect to matched group, the extremity autonomic activities is normal, painful, sense of touch and warm-cold sensitivity exist, growth promoter is good, do not find the bad performance of neuromuscular, curative effect obviously is better than matched group, and the two relatively has notable difference.
Therefore, above all experiments show that Herba Saussureae Involueratae injection changes route of administration can obviously increase its curative effect, is better than original route of administration, is worth at clinical expansion.
Two, toxicologic study
Acute toxicity test shows that the mouse tail vein injection Herba Saussureae Involueratae injection is not measured LD 50
Long term toxicity test: mice group, every day tail vein injection once, connect and annotate 90d, the result, administration group mice and control group mice movable, search for food, drinking-water, body weight and multinomial observation indexs such as substantial viscera pathologic finding and histopathology detect, result of the test is not all found any toxicity; Hemogram and hepatic and renal function index and the equal no significant difference of matched group.
The blood vessel irritation of this medicine, allergy and hemolytic test all are negative.
In sum, Herba Saussureae Involueratae injection is a kind of antibiosis anti-inflammatory drug preferably, to various urgency, chronic rheumatic arthritis, scapulohumeral periarthritis, rheumatoid arthritis and bone joint pain, sciatica, arthritis, radiculitis, Radial styloid tenosynovitis, sacroiliitis, disease treatment such as knee-joint pain and sciatica has the important clinical meaning, and changing original intramuscular administration is intravenously administrable, can obviously increase its antiinflammatory, detumescence, the analgesic clinical efficacy that waits, there is not tangible toxicity in addition, prolonged application safety, therefore, being worth clinical further applies.
The specific embodiment:
Further specify the present invention by the following examples, include but not limited to the following example.
Embodiment 1:
The preparation method of injection of the present invention:
Prescription: Herba Saussureae Involueratae 500g
F-68 4g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 4g, stirs, and regulates pH value to 6.0~8.0 with 40% sodium hydroxide solution, filters with microporous filter membrane (0.2 μ m), and filtrate adds the nearly 1000ml of injection water, embedding, and sterilization, promptly.
Embodiment 2
The preparation process of freeze-dried powder of the present invention is as follows:
Prescription: Herba Saussureae Involueratae 2500g
F-68 20g mannitol 50g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and mannitol, stirs, regulate pH value to 6.0~8.0 with 40% sodium hydroxide solution, filter with microporous filter membrane (0.2 μ m), filtrate adds the nearly full dose of injection water, the filtrate fill in the cillin bottle of 15ml, every bottled 2~7ml.And be placed in the freeze drying box pre-freeze evacuation after 3~5 hours.After the lyophilization 24 hours, tamponade, roll lid; Make dried frozen aquatic products, promptly get 500 bottles.
Embodiment 3
The preparation process of sterilized powder of the present invention is as follows:
Prescription: Herba Saussureae Involueratae 2500g
F-68 20g mannitol 200g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and mannitol, stirs, and regulates pH value to 6.0~8.0 with 40% sodium hydroxide solution, filter with microporous filter membrane (0.2 μ m), filtrate is sprayed with the spray drying tower under the aseptic condition, makes sterilized powder, packing, labeling, promptly.
Embodiment 4
The preparation of concentrated solution for injection of the present invention:
Prescription: Herba Saussureae Involueratae 2500g
F-68 20g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68, stirs, and regulates pH value to 6.0~8.0 with 40% sodium hydroxide solution, filter with microporous filter membrane (0.2 μ m), and sterilization, promptly.
Embodiment 5
The preparation of the present invention's 5% glucose injection:
Prescription: Herba Saussureae Involueratae 500g
F-68?4g
Glucose 50g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and glucose is an amount of, stirs, and regulates pH value to 6.0~8.0 with 40% sodium hydroxide solution, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.
Embodiment 6
The preparation of the present invention's 0.9% sodium chloride injection:
Prescription: Herba Saussureae Involueratae 500g
F-68 4g
Glucose 9g
Water for injection adds to 1000ml
Preparation method:
Get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 0.3g and sodium chloride 9g, stirs, and regulates pH value to 6.0~8.0 with 40% sodium hydroxide solution, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.

Claims (5)

1. a folk prescription injection that is used for diseases such as various acute and chronic rheumatic arthritis, scapulohumeral periarthritis, rheumatoid arthritis and bone joint pain is characterized in that with the Herba Saussureae Involueratae being that raw material and adjuvant are made.
2. the new route of administration of claim 1 refers to that Herba Saussureae Involueratae injection is used for multiple intravenously administrables such as intravenous drip, intravenous injection.
3. the ejection preparation of claim 1 is characterized in that small-volume injection (injection, concentrated solution for injection), bulk capacity injection (5% glucose injection, 0.9% sodium chloride injection) and specific type injection dosage forms such as (lyophilized powder, sterilized powders).
4. the injection of claim 3 is characterized in that, contains excipient in the preparation, and excipient is selected from: mannitol, sorbitol, lactose.
5. the preparation method of any one injection of claim 1-4 is characterized in that:
(1) preparation process of injection is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, it is an amount of that filtrate adds F-68, stirs, and with 40% sodium hydroxide solution regulated value to 6.0~8.0, filters with microporous filter membrane (0.2 μ m), and filtrate adds the nearly full dose of injection water, embedding, and sterilization, promptly.
(2) preparation process of freeze-dried powder is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, it is an amount of that filtrate adds F-68, stirs, and with 40% sodium hydroxide solution regulated value to 6.0~8.0, filters with microporous filter membrane (0.2 μ m), and filtrate adds the nearly full dose of injection water, the filtrate fill in the cillin bottle of 20ml, every bottled 5~7ml.And be placed in the freeze drying box pre-freeze evacuation after 3~5 hours.After the lyophilization 24 hours, tamponade, roll lid, make dried frozen aquatic products, promptly;
(3) preparation process of sterilized powder is as follows: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Getting this solution filters, it is an amount of that filtrate adds F-68, stir, with 40% sodium hydroxide solution regulated value to 6.0~8.0, after an amount of dissolving of adding mannitol, filter with microporous filter membrane (0.2 μ m), filtrate is sprayed with the spray drying tower under the aseptic condition, makes the aseptic powder art, packing, labeling, promptly.
(4) preparation of concentrated solution for injection: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 5g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and mannitol is an amount of, stirs, with 40% sodium hydroxide solution regulated value to 6.0~8.0, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.
The preparation of (5) 5% glucose injections: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 10ml and contains crude drug 1g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and glucose is an amount of, stirs, with 40% sodium hydroxide solution regulated value to 6.0~8.0, filter with microporous filter membrane (0.2 μ m), and embedding, sterilization, promptly.
The preparation of (6) 0.9% sodium chloride injections: get Herba Saussureae Involueratae, add 85% alcohol dipping 14 days, filter, filtrate is concentrated into every 1ml and contains crude drug 10g, puts in the container in 110 ℃, 0.1kP sterilization 45 minutes, places 1~3 month.Get this solution and filter, filtrate adds F-68 and sodium chloride is an amount of, stirs, and with 40% sodium hydroxide solution regulated value to 6.0~8.0, filters with microporous filter membrane (0.2 μ m), and filtrate is evaporated under aseptic condition in right amount, embedding, and sterilization, promptly.
CN 200510087732 2005-08-08 2005-08-08 Novel drug administering route of saussurea involucrate injection and its preparation process Pending CN1733038A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510087732 CN1733038A (en) 2005-08-08 2005-08-08 Novel drug administering route of saussurea involucrate injection and its preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510087732 CN1733038A (en) 2005-08-08 2005-08-08 Novel drug administering route of saussurea involucrate injection and its preparation process

Publications (1)

Publication Number Publication Date
CN1733038A true CN1733038A (en) 2006-02-15

Family

ID=36075793

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510087732 Pending CN1733038A (en) 2005-08-08 2005-08-08 Novel drug administering route of saussurea involucrate injection and its preparation process

Country Status (1)

Country Link
CN (1) CN1733038A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209274B (en) * 2007-12-25 2011-05-11 新疆维吾尔自治区药物研究所 Saussurea involucrata extract and and producing method thereof
CN104435043A (en) * 2014-12-05 2015-03-25 新疆银朵兰维药股份有限公司 Medicine for treating arthritis-induced arthralgia and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101209274B (en) * 2007-12-25 2011-05-11 新疆维吾尔自治区药物研究所 Saussurea involucrata extract and and producing method thereof
CN104435043A (en) * 2014-12-05 2015-03-25 新疆银朵兰维药股份有限公司 Medicine for treating arthritis-induced arthralgia and preparation method thereof

Similar Documents

Publication Publication Date Title
CA2594202A1 (en) Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
CN1748736A (en) New medicine administration path for reducing heat and detoxicating injection an dits preparing process
CN1207022C (en) Medicinal composition for promoting bone-fracture healing and bone-joint injure repairing
CN1733038A (en) Novel drug administering route of saussurea involucrate injection and its preparation process
CN1269498C (en) Chinese medicinal composition possessing antipyretic and its preparation method and quality control method
CN1876045A (en) A Chinese medicinal composition, its preparation process and quality control method
CN1931190A (en) Toad skin extract and its medicine prepn and their prepn
CN1060344C (en) Shumaining preparation for curing ischemic angiocardiopathy or cerebrovascular disease
CN102406665A (en) Application of physically modified cobra venom in preparing medicine for treating arthritis
CN1730014A (en) Novel drug administration route of semen armeniacae amarum injection, its preparation process and new indications
CN1733013A (en) Novel route for administering hairy holly injection and preparation process thereof
CN1698803A (en) Compound notoginseng injection and its preparation process
CN1799612A (en) Novel drug administering route of 'Qu Gan Re' injection, its preparation process and novel indications
CN1751714A (en) Novel administration route for compound injection contg. dandelion and its prepn. method
CN1768762A (en) Novel drug administering route of pantocrine injection, its preparation process and novel indications
CN1107501C (en) Albendazole emulsion
CN102048949A (en) Use of lycopodium clavatum in preparation of medicament for treating bone diseases
CN1457780A (en) Total alkaloid composition from plant and its pharmaceutical preparation
CN1943726A (en) A Chinese traditional medicinal composition for treatment of ischemic apoplexy and its preparation method
CN100350932C (en) Medicine for non operation treating nasitis and pharyngolaryngitis
CN1100550C (en) Chinese medicine composition for curing various cancers
CN1432391A (en) Recipe of Chinese medicine with treating and health care functions
CN101966245B (en) Compound injection for curing viral diseases in livestock and poultry and preparation method thereof
CN1204891C (en) Injection containing tramadol and its application
CN1259949C (en) Capsule for treating wound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Lu

Document name: Notification before expiration of term

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication